Cargando…

Treatments affecting the rate of asbestos-induced mesotheliomas.

256 Wistar rats received a single injection into the right pleural cavity of UICC crocidolite in order to induce mesotheliomas. They were then given right intrapleural injectons of BCG, crystalline silica, talc, carrageenan or saline (as a control). There was no significant change in the mesotheliom...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, J. C., Hill, R. J., Berry, G., Wagner, M. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1980
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010342/
https://www.ncbi.nlm.nih.gov/pubmed/6252922
_version_ 1782136302305542144
author Wagner, J. C.
Hill, R. J.
Berry, G.
Wagner, M. M.
author_facet Wagner, J. C.
Hill, R. J.
Berry, G.
Wagner, M. M.
author_sort Wagner, J. C.
collection PubMed
description 256 Wistar rats received a single injection into the right pleural cavity of UICC crocidolite in order to induce mesotheliomas. They were then given right intrapleural injectons of BCG, crystalline silica, talc, carrageenan or saline (as a control). There was no significant change in the mesothelioma rate in the rats exposed to BCG, silica or talc, but there was a 3-fold increase in mesothelioma incidence in the group injected with carrageenan.
format Text
id pubmed-2010342
institution National Center for Biotechnology Information
language English
publishDate 1980
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20103422009-09-10 Treatments affecting the rate of asbestos-induced mesotheliomas. Wagner, J. C. Hill, R. J. Berry, G. Wagner, M. M. Br J Cancer Research Article 256 Wistar rats received a single injection into the right pleural cavity of UICC crocidolite in order to induce mesotheliomas. They were then given right intrapleural injectons of BCG, crystalline silica, talc, carrageenan or saline (as a control). There was no significant change in the mesothelioma rate in the rats exposed to BCG, silica or talc, but there was a 3-fold increase in mesothelioma incidence in the group injected with carrageenan. Nature Publishing Group 1980-06 /pmc/articles/PMC2010342/ /pubmed/6252922 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Wagner, J. C.
Hill, R. J.
Berry, G.
Wagner, M. M.
Treatments affecting the rate of asbestos-induced mesotheliomas.
title Treatments affecting the rate of asbestos-induced mesotheliomas.
title_full Treatments affecting the rate of asbestos-induced mesotheliomas.
title_fullStr Treatments affecting the rate of asbestos-induced mesotheliomas.
title_full_unstemmed Treatments affecting the rate of asbestos-induced mesotheliomas.
title_short Treatments affecting the rate of asbestos-induced mesotheliomas.
title_sort treatments affecting the rate of asbestos-induced mesotheliomas.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010342/
https://www.ncbi.nlm.nih.gov/pubmed/6252922
work_keys_str_mv AT wagnerjc treatmentsaffectingtherateofasbestosinducedmesotheliomas
AT hillrj treatmentsaffectingtherateofasbestosinducedmesotheliomas
AT berryg treatmentsaffectingtherateofasbestosinducedmesotheliomas
AT wagnermm treatmentsaffectingtherateofasbestosinducedmesotheliomas